Patients had preexisting T cells to multiple prostate-specific proteins. Shown are the number and % of patients with IFNγ-, granzyme B- (Grz), IL-10-, or IL-6-secreting responses to one or more (or none) of the three prostate cancer-associated proteins (PAP, PSA or AR)

IFNγGrzIL-10IL-6
n (%)n (%)n (%)n (%)
None4 (13.3)3 (10)1 (3.3)9 (30)
PAP0000
PSA0000
AR2 (6.6)3 (10)4 (13.3)0
PAP + PSA0000
PSA + AR01 (3.3)00
PAP + AR9 (30)7 (23.3)9 (30)13 (43)
PAP + AR + PSA15 (50)16 (53.3)16 (53.3)8 (27)